News
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
The Canadian Press on MSN1d
New obesity guidelines for kids address when medication is an optionA new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...
For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...
Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...
The judge, James Boasberg, ruled that there was “probable cause” to find officials in contempt for violating his order. And ...
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a ...
GLP-1s like Ozempic, as well as weight-loss surgery, are among the recommendations to treat childhood obesity in the first guideline update in Canada in almost 20 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results